NASDAQ:IRTCIrhythm Technologies Stock Price, Forecast & News

Irhythm Technologies' stock was trading at $85.54 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, IRTC shares have increased by 31.2% and is now trading at $112.26. View which stocks have been most impacted by Coronavirus.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Irhythm Technologies in the last year. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Irhythm Technologies.

Irhythm Technologies is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Irhythm Technologies.

Irhythm Technologies Inc (NASDAQ:IRTC) announced its quarterly earnings results on Thursday, May, 7th. The company reported ($0.34) earnings per share for the quarter, beating the consensus estimate of ($0.57) by $0.23. The company had revenue of $63.50 million for the quarter, compared to the consensus estimate of $61.40 million. Irhythm Technologies had a negative return on equity of 49.99% and a negative net margin of 24.34%. The business's quarterly revenue was up 35.1% on a year-over-year basis. During the same period in the prior year, the company earned ($0.33) EPS. View Irhythm Technologies' earnings history.

Irhythm Technologies issued an update on its first quarter 2020 After-Hours earnings guidance on Thursday, April, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $61-62 million, compared to the consensus revenue estimate of $60.67 million.

8 Wall Street analysts have issued 1 year target prices for Irhythm Technologies' stock. Their forecasts range from $112.00 to $142.00. On average, they anticipate Irhythm Technologies' stock price to reach $130.67 in the next twelve months. This suggests a possible upside of 16.4% from the stock's current price. View analysts' price targets for Irhythm Technologies.

Media coverage about IRTC stock has been trending negative on Tuesday, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Irhythm Technologies earned a news sentiment score of -2.1 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news about Irhythm Technologies.

Some companies that are related to Irhythm Technologies include ABIOMED (ABMD), Hill-Rom (HRC), Penumbra (PEN), Novocure (NVCR), Tandem Diabetes Care (TNDM), Globus Medical (GMED), Haemonetics (HAE), Integra Lifesciences (IART), Nevro (NVRO), ICU Medical (ICUI), Inovio Pharmaceuticals (INO), NuVasive (NUVA), Merit Medical Systems (MMSI), Inspire Medical Systems (INSP) and Inari Medical (NARI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Irhythm Technologies investors own include Alibaba Group (BABA), NVIDIA (NVDA), DexCom (DXCM), Paypal (PYPL), Teladoc Health (TDOC), Shopify (SHOP), Veeva Systems (VEEV), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and Paycom Software (PAYC).

(IRTC) raised $76 million in an initial public offering (IPO) on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

Irhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

Shares of IRTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of IRTC stock can currently be purchased for approximately $112.26.

Irhythm Technologies has a market capitalization of $3.04 billion and generates $214.55 million in revenue each year. The company earns $-54,570,000.00 in net income (profit) each year or ($2.16) on an earnings per share basis. Irhythm Technologies employs 748 workers across the globe.

The official website for Irhythm Technologies is www.irhythmtech.com.

Irhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The company can be reached via phone at 415-632-5700 or via email at [email protected]